Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics crawled date : 2022 - 01 - 04 save search
Travere Therapeutics Appoints Jula Inrig, M.D., as Chief Medical Officer
Published: 2022-01-04 (Crawled : 23:00) - travere.com
TVTX | $5.745 -1.8% -1.83% 1.2M
|
Health Technology
|
| O: 0.26%
H: 0.88%
C: -4.22%
therapeutics
Oncternal Therapeutics Announces Agreement with U.S. FDA on Phase 3 Registrational Study Design for Zilovertamab in the Treatment of Mantle Cell Lymphoma
Published: 2022-01-04 (Crawled : 23:00) - biospace.com/
ONCT | $8.98 5.03% 4.79% 960
|
Health Technology
|
| O: 1.65%
H: 0.4%
C: -5.26%
treatment fda therapeutics cel phase 3 designation
ProQR Announces Last Patient Has Completed 12 Month Visit in Phase 2/3 Illuminate Trial of Sepofarsen
Published: 2022-01-04 (Crawled : 23:00) - biospace.com/
PRQR | News | $2.04 2.0% 1.96% 180K
|
Health Technology
|
| O: 0.37%
H: 6.04%
C: 3.45%
phase 2 phase 2/3 trial
Fulcrum Therapeutics® Appoints Esther Rajavelu as Chief Financial Officer
Published: 2022-01-04 (Crawled : 20:00) - biospace.com/
FULC | $7.445 2.69% 2.62% 510K
|
Health Technology
|
| O: -1.18%
H: 1.36%
C: -2.33%
therapeutics
TCR² Therapeutics and Arbor Biotechnologies Establish Collaboration to Advance Allogeneic TRuC-T Cell Therapies
Published: 2022-01-04 (Crawled : 20:00) - biospace.com/
TCRR 4 | $1.48 3.38% 3.9M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: 0.0%
therapeutics cel collaboration biotech iot therapy t-cell
Lineage Cell Therapeutics to Present at H.C. Wainwright Bioconnect Virtual Conference
Published: 2022-01-04 (Crawled : 19:00) - biospace.com/
LCTX | $1.14 0.0% 330K
|
Health Technology
|
| O: 1.21%
H: 0.8%
C: -9.56%
conference therapeutics cel
Halozyme to Present Virtually at the 40th Annual J.P. Morgan Health Care Conference
Published: 2022-01-04 (Crawled : 19:00) - biospace.com/
HALO M | $38.94 0.59% 0.59% 560K
|
Health Technology
|
| O: 0.02%
H: 3.07%
C: -2.48%
health conference
RAAS Investors Have Opportunity to Lead Cloopen Group Holding Limited Securities Fraud Lawsuit
Published: 2022-01-04 (Crawled : 19:00) - prnewswire.com
RAAS | $1.13 10.62% 14K
|
Information
|
| O: -0.37%
H: 4.43%
C: -5.17%
RVNC | $3.665 0.69% 0.68% 1.6M
|
Health Technology
|
| O: 0.25%
H: 0.37%
C: -5.83%
group
RVNC Investors Have Opportunity to Lead Revance Therapeutics, Inc. Securities Fraud Lawsuit
Published: 2022-01-04 (Crawled : 19:00) - prnewswire.com
RVNC | $3.665 0.69% 0.68% 1.6M
|
Health Technology
|
| O: 0.25%
H: 0.37%
C: -5.83%
therapeutics
Spero Therapeutics Announces Lifting of FDA Clinical Trial Hold on SPR720
Published: 2022-01-04 (Crawled : 19:00) - biospace.com/
SPRO | $1.435 2.14% 2.09% 120K
|
Health Technology
|
| O: 3.96%
H: 0.0%
C: -5.33%
spr720 fda trial therapeutics
Outlook Therapeutics to Present at the H.C. Wainwright BioConnect Conference
Published: 2022-01-04 (Crawled : 16:00) - biospace.com/
OTLK | News P | $8.2 1.36% 1.34% 150K
|
Health Technology
|
| O: 0.0%
H: 2.4%
C: -4.79%
conference therapeutics
Allogene Therapeutics to Present at the Virtual 40th Annual J.P. Morgan Healthcare Conference
Published: 2022-01-04 (Crawled : 16:00) - biospace.com/
ALLO | $3.365 -1.03% -1.04% 1.6M
|
Health Technology
|
| O: -0.26%
H: 0.92%
C: -4.98%
health thc conference therapeutics j.p. morgan healthcare conference
G1 Therapeutics to Participate in the 40th Annual J.P. Morgan and H.C. Wainwright BioConnect Virtual Conferences in January 2022
Published: 2022-01-04 (Crawled : 15:30) - biospace.com/
GTHX | $4.19 2.2% 2.15% 350K
|
Health Technology
|
| O: 2.92%
H: 5.01%
C: 1.04%
conference therapeutics
Tenax Therapeutics Provides Update on TNX-102, TNX-103 and TNX-201 Clinical Programs
Published: 2022-01-04 (Crawled : 15:30) - biospace.com/
TENX | $3.59 0.84% 0.84% 12K
|
Health Technology
|
| O: 7.21%
H: 22.64%
C: -15.13%
tnx-102 therapeutics
Viridian Therapeutics Submits Investigational New Drug Application for VRDN-002 to the U.S. Food and Drug Administration
Published: 2022-01-04 (Crawled : 15:30) - biospace.com/
VRDN | $14.23 -0.49% -0.49% 540K
|
Health Care and Social Assistan...
|
| O: 0.19%
H: 0.87%
C: -0.38%
vrdn-002 new drug application drug therapeutics food
Relay Therapeutics Announces Dosing of First Patient in First-in-Human Trial of RLY-2608 and Initiation of Expansion Cohorts for First-In-Human Trial of RLY-4008
Published: 2022-01-04 (Crawled : 15:30) - biospace.com/
RLAY | $5.89 -1.01% -1.02% 800K
|
Health Technology
|
| O: 4.88%
H: 3.19%
C: -1.5%
rly-2608 expansion trial therapeutics
Aldeyra Therapeutics Completes Enrollment in Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy
Published: 2022-01-04 (Crawled : 15:30) - biospace.com/
ALDX | $3.91 -0.51% -0.51% 450K
|
Health Technology
|
| O: 0.7%
H: 2.33%
C: -1.4%
adx-2191 trial therapeutics phase 3 enroll
Cognition Therapeutics Receives Grant from Michael J. Fox Foundation to Support Development of Sigma-2 Receptor Modulator for Parkinson’s Disease
Published: 2022-01-04 (Crawled : 15:30) - biospace.com/
CGTX | News | $2.02 8.6% 7.92% 140K
|
|
| O: 2.08%
H: 14.42%
C: 7.99%
parkinson therapeutics disease
Plus Therapeutics Announces Two Significant Milestones Toward cGMP Manufacture of its Lead Investigational Radiotherapeutic
Published: 2022-01-04 (Crawled : 15:00) - biospace.com/
PSTV | News | $1.65 -0.6% -0.61% 17K
|
Health Technology
|
| O: 83.35%
H: 8.0%
C: -36.0%
therapeutics iot milestone
Viracta Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
Published: 2022-01-04 (Crawled : 15:00) - biospace.com/
VIRX | $0.831 -5.57% -5.9% 84K
|
Manufacturing
|
| O: 1.79%
H: 0.0%
C: -8.04%
conference therapeutics
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.